Clinical trials
Heart Diseases trials in Spain with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2012 | 3 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 2 |
| Fundación EPIC | 2 |
| P+F Products + Features GmbH | 2 |
| Weill Medical College of Cornell University | 2 |
| Abbott Medical Devices | 1 |
| Cardiac Dimensions, Inc. | 1 |
| Edwards Lifesciences | 1 |
| Elisabeth-TweeSteden Ziekenhuis | 1 |
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 24 |
| Cardiovascular Diseases | 9 |
| Coronary Artery Disease | 5 |
| Atrial Fibrillation | 4 |
| Heart Failure | 4 |
| Myocardial Ischemia | 4 |
| Heart Valve Diseases | 3 |
| Arrhythmias, Cardiac | 2 |
| Arteriosclerosis | 2 |
| Coronary Disease | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.